These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4022202)

  • 1. [Fibrin degradation products and prothrombin activity in cerebral hemorrhage].
    Szirmai I; Romhányi M; Móró Z; Kartai Z
    Nervenarzt; 1985 Jun; 56(6):316-22. PubMed ID: 4022202
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlation between coagulation and fibrinolysis in patient with cerebrovascular accident at acute stage].
    Takemoto Y; Fukuda A; Tanaka S; Tanabe J; Ikeda H; Fujii C; Kohama A
    No To Shinkei; 1982 Oct; 34(10):1007-10. PubMed ID: 7150448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of cerebrospinal fluid fibrinolytic activity in meningeal hemorrhages as a result of aneurysm rupture].
    Rivierez M; Dagreou F; Guggiari M; Ankri A; Crespo B; Philippon J
    Neurochirurgie; 1983; 29(2):119-23. PubMed ID: 6888630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombin-III levels in patients with acute cerebrovascular disease].
    Han ZY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Feb; 21(1):41-2, 63. PubMed ID: 3402275
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
    Dube B; Somani PN; Tripathi GK; Dube RK; Bhattacharya SK
    J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
    Li F; Zhang G; Zhao W
    Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta].
    Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K
    No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombin converting-and fibrinolytic effects of ecarin.
    Kornalík F
    Czech Med; 1985; 8(1):51-4. PubMed ID: 3922719
    [No Abstract]   [Full Text] [Related]  

  • 9. [Status of the blood clotting system in stroke (review of the Soviet and foreign literature)].
    Martynov FI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(9):1400-5. PubMed ID: 7034425
    [No Abstract]   [Full Text] [Related]  

  • 10. [Local fibrinolysis in cerebral and subarachnoid hemorrhage].
    Vilchez JJ; Aznar JA; Benedito J; Tascón A; González A; Jiménez C; Vilela C
    Rev Clin Esp; 1978 Aug; 150(3-4):193-5. PubMed ID: 715282
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipids metabolism of the patients with subarachnoid hemorrhage due to ruptured intracranial aneurysm, in comparison with other cerebrovascular diseases].
    Nonaka N; Matsukado Y; Oribe Y; Sano Y; Ito Y; Kuratsu J; Seto H; Miura G
    No To Shinkei; 1984 Apr; 36(4):389-95. PubMed ID: 6743410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-antithrombin complex levels in subarachnoid hemorrhage.
    Fujii Y
    J Neurosurg; 1998 Mar; 88(3):614-5. PubMed ID: 9488325
    [No Abstract]   [Full Text] [Related]  

  • 14. [Assay of serum glycoprotein levels in patients with central nervous system disease].
    Luo ZM; Hu CH; Gao JZ
    Hua Xi Yi Ke Da Xue Xue Bao; 1987 Dec; 18(4):365-7. PubMed ID: 3449427
    [No Abstract]   [Full Text] [Related]  

  • 15. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase.
    Jin L; Jin H; Zhang G; Xu G
    Clin Hemorheol Microcirc; 2000; 23(2-4):213-8. PubMed ID: 11321442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage.
    Vermeulen M; van Vliet HH; Lindsay KW; Hijdra A; van Gijn J
    J Neurosurg; 1985 Oct; 63(4):573-7. PubMed ID: 3897478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage.
    Sandhu R; Aronow WS; Rajdev A; Sukhija R; Amin H; D'aquila K; Sangha A
    Am J Cardiol; 2008 Sep; 102(5):632-4. PubMed ID: 18721527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma D-dimer changes in chronic severe hepatitis B patients].
    Yin YM; Liu AP; Geng AW; Zhang Y
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):59-60. PubMed ID: 21272463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.